{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:03:39Z","timestamp":1785402219947,"version":"3.56.0"},"reference-count":98,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","award":["K23MD017217"],"award-info":[{"award-number":["K23MD017217"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]},{"award":["K23MD017217"],"award-info":[{"award-number":["K23MD017217"]}],"id":[{"id":"https:\/\/ror.org\/0493hgw16","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Healthcare"],"abstract":"<jats:p>Background: Southeast Asian Americans (SEAAs) experience a disproportionately high burden of hepatocellular carcinoma (HCC), with incidence in several subgroups (i.e., Cambodian, Laotian, and Vietnamese individuals) reaching up to nine times that of non-Hispanic Whites. HCC in SEAAs is largely driven by chronic hepatitis B (HBV), hepatitis C (HCV), metabolic dysfunction\u2013associated steatotic liver disease (MASLD), and alcohol-associated liver disease (ALD). Despite established screening guidelines, under-detection and delayed diagnosis remain common. Objective: To summarize epidemiologic patterns, risk factors, screening challenges, and potential interventions aimed at reducing HCC disparities among SEAAs. Design and Methods: This narrative review synthesized evidence from population based epidemiologic studies, community-based interventions, health services research, and policy analyses. Attention was given to studies reporting disaggregated SEAA subgroup data. Findings derived from SEAA specific studies were distinguished from evidence drawn from broader Asian American or general cirrhosis populations, with inferential steps explicitly noted where subgroup specific data were limited. Key Findings: HCC incidence varies widely across SEAA subgroups, with elevated HBV- and HCV-related HCC in Vietnamese, Cambodian, and Laotian communities, and increasing MASLD-related HCC including among lean individuals who fall outside many surveillance frameworks. Screening and surveillance remain suboptimal, with fewer than 30% of patients with cirrhosis receiving recommended semiannual HCC surveillance and even lower uptake among SEAAs. Barriers include low HBV\/HCV screening rates, limited disease awareness, language barriers, underinsurance, provider knowledge gaps, and lack of automated EHR-based reminders. Structural challenges such as poverty, transportation barriers, and limited access to specialty care further delay diagnosis. Proposed Interventions: Culturally tailored outreach programs, bilingual navigators, and community-based screening initiatives have demonstrated improved HBV\/HCV testing and linkage to care. AI-enabled EHR tools may enhance identification of high-risk patients, streamline follow-up, and increase surveillance adherence. Expanded use of non-invasive fibrosis assessment and recognition of MASLD-related risk in non-obese individuals may support earlier detection. Policy priorities include mandatory Asian subgroup data disaggregation, expanded insurance coverage, and strengthened community-level healthcare infrastructure. Conclusions: SEAAs face a substantial and preventable HCC burden. A coordinated approach combining culturally tailored community engagement, improved provider support systems, and policy reforms is essential to improving early detection and reducing HCC disparities in this diverse population.<\/jats:p>","DOI":"10.3390\/healthcare14101314","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:33:37Z","timestamp":1778589217000},"page":"1314","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatocellular Carcinoma in Southeast Asian Americans: Epidemiologic Trends, Screening Challenges, and Policy Implications"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0731-7309","authenticated-orcid":false,"given":"Ahauve M.","family":"Orusa","sequence":"first","affiliation":[{"name":"Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7931-1308","authenticated-orcid":false,"given":"Abby M.","family":"Lohr","sequence":"additional","affiliation":[{"name":"Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1547-6186","authenticated-orcid":false,"given":"Khalid F.","family":"Abu-Zeinah","sequence":"additional","affiliation":[{"name":"Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5005-4806","authenticated-orcid":false,"given":"Irene G.","family":"Sia","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7658-6763","authenticated-orcid":false,"given":"Jennifer L.","family":"Ridgeway","sequence":"additional","affiliation":[{"name":"Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aminah","family":"Jatoi","sequence":"additional","affiliation":[{"name":"Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen H.","family":"Tran","sequence":"additional","affiliation":[{"name":"Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/jnci\/djy184","article-title":"Hepatocellular Carcinoma: A Roadmap to Reduce Incidence and Future Burden","volume":"111","author":"Singal","year":"2019","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1002\/cncr.31598","article-title":"Disparities in hepatocellular carcinoma incidence by race\/ethnicity and geographic area in California: Implications for prevention","volume":"124","author":"Yang","year":"2018","journal-title":"Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/onco.13748","article-title":"Disparities in Cancer Care and the Asian American Population","volume":"26","author":"Lee","year":"2021","journal-title":"Oncologist"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1097\/00004836-200211002-00002","article-title":"Hepatocellular carcinoma: An epidemiologic view","volume":"35","year":"2002","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e252208","DOI":"10.1001\/jamanetworkopen.2025.2208","article-title":"Liver Cancer Etiology in Asian Subgroups and American Indian, Black, Latino, and White Populations","volume":"8","author":"Pinheiro","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1579\/0044-7447(2007)36[458:MSAEFR]2.0.CO;2","article-title":"Model selection and evaluation for risk assessment of dioxin-contaminated sites","volume":"36","author":"Wiberg","year":"2007","journal-title":"Ambio"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/jnci\/djy051","article-title":"Striking Racial\/Ethnic Disparities in Liver Cancer Incidence Rates and Temporal Trends in California, 1988\u20132012","volume":"110","author":"Pham","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e2520294","DOI":"10.1001\/jamanetworkopen.2025.20294","article-title":"Hepatocellular Carcinoma Surveillance and Survival in a Contemporary Asia-Pacific Cohort","volume":"8","author":"Lim","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1136\/gut.2003.033324","article-title":"Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma","volume":"53","author":"Chan","year":"2004","journal-title":"Gut"},{"key":"ref_11","first-page":"9","article-title":"Prevention of hepatitis B virus-related hepatocellular carcinoma","volume":"7","author":"Lin","year":"2021","journal-title":"Hepatoma Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1158\/1055-9965.EPI-24-0626","article-title":"Hepatocellular Carcinoma Etiology Drives Survival Outcomes: A Population-Based Analysis","volume":"33","author":"Cranford","year":"2024","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: Trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e773","DOI":"10.1002\/hsr2.773","article-title":"Hepatitis B virus screening in Asian immigrants: Community-based campaign to increase screening and linkage to care: A cross-sectional study","volume":"6","author":"Win","year":"2023","journal-title":"Health Sci. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s41124-018-0034-7","article-title":"Racial\/ethnic- and county-specific prevalence of chronic hepatitis B and its burden in California","volume":"3","author":"Toy","year":"2018","journal-title":"Hepatol. Med. Policy"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10900-018-0573-2","article-title":"Prevalence of Viral Hepatitis in Foreign-Born Populations in the Baltimore-Washington Metropolitan Area, 2009\u20132015","volume":"44","author":"Juon","year":"2019","journal-title":"J. Community Health"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e0118","DOI":"10.1097\/HC9.0000000000000118","article-title":"Prevalence and awareness of Hepatitis B virus infection in the United States: January 2017\u2013March 2020","volume":"7","author":"Bixler","year":"2023","journal-title":"Hepatol. Commun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/hep.30831","article-title":"Chronic Hepatitis B Prevalence Among Foreign-Born and U.S.-Born Adults in the United States, 1999\u20132016","volume":"71","author":"Le","year":"2020","journal-title":"Hepatology"},{"key":"ref_19","first-page":"1","article-title":"Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations\u2014United States, 2023","volume":"72","author":"Conners","year":"2023","journal-title":"Morb. Mortal. Wkly. Rep. Recomm. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"19960","DOI":"10.1002\/cam4.6537","article-title":"Decreasing incidence of hepatocellular carcinoma among most racial groups: SEER-22, 2000\u20132019","volume":"12","author":"Devesa","year":"2023","journal-title":"Cancer Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1365-2893.2011.01577.x","article-title":"Hepatocellular carcinoma screening practices and impact on survival among hepatitis B-infected Asian Americans","volume":"19","author":"Sarkar","year":"2012","journal-title":"J. Viral Hepat."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10903-016-0342-1","article-title":"HCV Prevalence in Asian Americans in California","volume":"19","author":"Lin","year":"2017","journal-title":"J. Immigr. Minor. Health"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Ma, Y., Wang, J., Xiao, W., and Fan, X. (2024). A review of MASLD-related hepatocellular carcinoma: Progress in pathogenesis, early detection, and therapeutic interventions. Front. Med., 11.","DOI":"10.3389\/fmed.2024.1410668"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1097\/HEP.0000000000001243","article-title":"Prevalence and predictors of cirrhosis and portal hypertension in the United States","volume":"82","author":"Younossi","year":"2025","journal-title":"Hepatology"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Paik, J.M., Hobbs, K., Gupta, A., Alkalbani, R.J., Reyes, M.A., and Younossi, Z.M. (2025). Prevalence of MASLD, Met-ALD, and ALD and Associated Fibrosis Among US Adults: Insights from NHANES 2017 to 2023. J. Clin. Gastroenterol., ahead of print.","DOI":"10.1097\/MCG.0000000000002202"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/HEP.0000000000000604","article-title":"National prevalence estimates for steatotic liver disease and subclassifications using consensus nomenclature","volume":"79","author":"Lee","year":"2024","journal-title":"Hepatology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/HEP.0000000000001211","article-title":"Prevalence of metabolic dysfunction-associated steatotic liver disease and fibrosis defined by liver elastography in the United States using National Health and Nutrition Examination Survey 2017-March 2020 and August 2021-August 2023 data","volume":"82","author":"Ruhl","year":"2025","journal-title":"Hepatology"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Aung, T.C.Z., Boonkaew, B., Chayanupatkul, M., Poovorawan, K., Chuaypen, N., and Tangkijvanich, P. (2025). The Distribution and Survival Association of Genetic Polymorphisms in Thai Patients with Hepatocellular Carcinoma According to Underlying Liver Disease. Genes, 16.","DOI":"10.3390\/genes16070808"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/apt.18473","article-title":"Alcohol-Related Liver Disease, Followed by Metabolic Dysfunction-Associated Steatotic Liver Disease, Emerges as the Fastest-Growing Aetiologies for Primary Liver Cancer in the United States","volume":"61","author":"Danpanichkul","year":"2025","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.cgh.2023.08.016","article-title":"Incidence of Etiology-specific Hepatocellular Carcinoma: Diverging Trends and Significant Heterogeneity by Race and Ethnicity","volume":"22","author":"Pinheiro","year":"2024","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_31","unstructured":"U.S. Preventive Services Task Force (2026, April 15). Hepatitis C Virus Infection in Adolescents and Adults: Screening. Available online: https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/recommendation\/hepatitis-c-screening."},{"key":"ref_32","unstructured":"U.S. Preventive Services Task Force (2026, April 15). Hepatitis B Virus Infection in Adolescents and Adults: Screening. Available online: https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/recommendation\/hepatitis-b-virus-infection-screening."},{"key":"ref_33","unstructured":"(2026, April 10). Clinical Testing and Diagnosis for Hepatitis B, Available online: https:\/\/www.cdc.gov\/hepatitis-b\/hcp\/diagnosis-testing\/index.html."},{"key":"ref_34","unstructured":"(2026, April 15). Significant Update to Hepatitis B Screening and Testing Recommendations, Available online: https:\/\/www.cdc.gov\/nchhstp\/director-letters\/updated-hepatitis-b-screening-recommendations.html."},{"key":"ref_35","unstructured":"(2026, April 15). Clinical Screening and Diagnosis for Hepatitis C, Available online: https:\/\/www.cdc.gov\/hepatitis-c\/hcp\/diagnosis-testing\/index.html."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.mayocpiqo.2019.04.005","article-title":"A Practical Guideline for Hepatocellular Carcinoma Screening in Patients at Risk","volume":"3","author":"Frenette","year":"2019","journal-title":"Mayo Clin. Proc. Innov. Qual. Outcomes"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e00877","DOI":"10.14309\/ctg.0000000000000877","article-title":"Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis at US Safety-Net Health Systems","volume":"16","author":"Wong","year":"2025","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s10900-020-00823-x","article-title":"Identifying Factors Associated with Cancer Screening in Immigrant Populations Living in New York City","volume":"45","author":"Makoni","year":"2020","journal-title":"J. Community Health"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1158\/1055-9965.EPI-14-0491","article-title":"Chronic hepatitis B and liver cancer risks among Asian immigrants in New York City: Results from a large, community-based screening, evaluation, and treatment program","volume":"23","author":"Pollack","year":"2014","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/hep.31309","article-title":"Use of Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Systematic Review and Meta-Analysis","volume":"73","author":"Wolf","year":"2021","journal-title":"Hepatology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e2411076","DOI":"10.1001\/jamanetworkopen.2024.11076","article-title":"Clinician-Level Knowledge and Barriers to Hepatocellular Carcinoma Surveillance","volume":"7","author":"Wong","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/hep.23615","article-title":"Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States","volume":"52","author":"Davila","year":"2010","journal-title":"Hepatology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1038\/ajg.2011.302","article-title":"Risk factors for early-onset and late-onset hepatocellular carcinoma in Asian immigrants with hepatitis B in the United States","volume":"106","author":"Wan","year":"2011","journal-title":"Am. J. Gastroenterol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12029-023-00944-1","article-title":"Interventions to Improve Surveillance for Hepatocellular Carcinoma in High-Risk Patients: A Scoping Review","volume":"55","author":"Beal","year":"2024","journal-title":"J. Gastrointest. Cancer"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.cgh.2014.06.031","article-title":"Practice patterns and attitudes of primary care providers and barriers to surveillance of hepatocellular carcinoma in patients with cirrhosis","volume":"13","author":"Tiro","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/phn.13298","article-title":"Factors affecting the compliance of hepatocellular carcinoma screening among high-risk populations: A systematic review and meta-analysis","volume":"41","author":"Feng","year":"2024","journal-title":"Public Health Nurs."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.2147\/JHC.S284430","article-title":"An Analysis of Individual and Contextual-Level Disparities in Screening, Treatment, and Outcomes for Hepatocellular Carcinoma","volume":"8","author":"Kronenfeld","year":"2021","journal-title":"J. Hepatocell. Carcinoma"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1111\/jocn.16140","article-title":"\u2018We can bear it!\u2019 Unpacking barriers to hepatocellular carcinoma screening among patients with hepatitis B: A qualitative study","volume":"31","author":"Li","year":"2022","journal-title":"J. Clin. Nurs."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s40615-020-00763-1","article-title":"Interventions to Reduce Healthcare Disparities in Cancer Screening Among Minority Adults: A Systematic Review","volume":"8","author":"Liu","year":"2021","journal-title":"J. Racial Ethn. Health Disparities"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e2223504","DOI":"10.1001\/jamanetworkopen.2022.23504","article-title":"Barriers to Surveillance for Hepatocellular Carcinoma in a Multicenter Cohort","volume":"5","author":"Parikh","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.cgh.2018.07.029","article-title":"Primary Care Provider Practice Patterns and Barriers to Hepatocellular Carcinoma Surveillance","volume":"17","author":"Simmons","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1353\/cpr.2022.0007","article-title":"Hepatitis B Screening, Vaccination, and Linkage to Care: Lessons Learned from a Mississippi Vietnamese Community","volume":"16","author":"Funchess","year":"2022","journal-title":"Prog. Community Health Partnersh."},{"key":"ref_53","first-page":"10","article-title":"Hepatitis B screening compliance and non-compliance among Chinese, Koreans, Vietnamese and Cambodians","volume":"3","author":"Ma","year":"2010","journal-title":"Clin. Med. Insights Gastroenterol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1080\/10810730.2024.2362882","article-title":"The Role of Culturally Appropriate Mediated Communication Strategies to Reduce Hepatitis B and Liver Cancer Disparities","volume":"29","author":"Zovich","year":"2024","journal-title":"J. Health Commun."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1158\/1055-9965.EPI-21-1035","article-title":"Asian American\/Pacific Islander and Hispanic Ethnic Enclaves, Neighborhood Socioeconomic Status, and Hepatocellular Carcinoma Incidence in California: An Update","volume":"31","author":"Sangaramoorthy","year":"2022","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s10903-023-01478-1","article-title":"Disparities in Hepatocellular Carcinoma Outcomes Among Subgroups of Asians and Pacific Islanders: A SEER Database Study","volume":"25","author":"Sempokuya","year":"2023","journal-title":"J. Immigr. Minor. Health"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/jvh.13981","article-title":"Screening rates for hepatitis B and C among low-income US veterans: Data from the National Veteran Homeless and Other Poverty Experiences Study","volume":"31","author":"Beydoun","year":"2024","journal-title":"J. Viral Hepat."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/MCG.0000000000001313","article-title":"Disparities in Hepatocellular Carcinoma Surveillance: Dissecting the Roles of Patient, Provider, and Health System Factors","volume":"54","author":"Ladhani","year":"2020","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s10900-020-00947-0","article-title":"Hepatitis B Testing Among Vietnamese in Metropolitan Atlanta: The Role of Healthcare-Related and Acculturation-Related Factors","volume":"46","author":"Vu","year":"2021","journal-title":"J. Community Health"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"393","DOI":"10.31557\/APJCP.2022.23.2.393","article-title":"Preventive Cancer Screening in Asian Americans: Need for Community Outreach Programs","volume":"23","author":"Wu","year":"2022","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1093\/jnci\/djac097","article-title":"Disparities in Risk of Advanced-Stage Liver Cancer and Mortality by Race and Ethnicity","volume":"114","author":"Li","year":"2022","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1007\/s10620-023-07840-5","article-title":"A Comparative Trial of Improving Care for Underserved Asian Americans Infected with Hepatitis B Virus","volume":"68","author":"Ma","year":"2023","journal-title":"Dig. Dis. Sci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1002\/cncr.31103","article-title":"The Asian American Network for Cancer Awareness, Research, and Training (AANCART)\u2019s contributions toward reducing Asian American cancer health disparities, 2000\u20132017","volume":"124","author":"Chen","year":"2018","journal-title":"Cancer"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"100379","DOI":"10.1016\/j.jve.2024.100379","article-title":"Existing knowledge, myths, and perceptions about hepatitis B and liver cancer within highly impacted immigrant communities","volume":"10","author":"Chen","year":"2024","journal-title":"J. Virus Erad."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.canep.2016.07.009","article-title":"Effectiveness of patient-targeted interventions to promote cancer screening among ethnic minorities: A systematic review","volume":"44","year":"2016","journal-title":"Cancer Epidemiol."},{"key":"ref_66","first-page":"20552076221076257","article-title":"Social media-based intervention to promote HBV screening and liver cancer prevention among Korean Americans: Results of a pilot study","volume":"8","author":"Hong","year":"2022","journal-title":"Digit. Health"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10903-007-9094-2","article-title":"The Jade Ribbon Campaign: A model program for community outreach and education to prevent liver cancer in Asian Americans","volume":"11","author":"Chao","year":"2009","journal-title":"J. Immigr. Minor. Health"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s10900-010-9339-1","article-title":"San Francisco hep B free: A grassroots community coalition to prevent hepatitis B and liver cancer","volume":"36","author":"Bailey","year":"2011","journal-title":"J. Community Health"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ypmed.2012.11.003","article-title":"Effectiveness of a culturally integrated liver cancer education in improving HBV knowledge among Asian Americans","volume":"56","author":"Juon","year":"2013","journal-title":"Prev. Med."},{"key":"ref_70","first-page":"455","article-title":"Multilevel factors influencing hepatitis B screening and vaccination among Vietnamese Americans in Atlanta, Georgia","volume":"87","author":"Frew","year":"2014","journal-title":"Yale J. Biol. Med."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Romeo, M., Dallio, M., Napolitano, C., Basile, C., Di Nardo, F., Vaia, P., Iodice, P., and Federico, A. (2025). Clinical Applications of Artificial Intelligence (AI) in Human Cancer: Is It Time to Update the Diagnostic and Predictive Models in Managing Hepatocellular Carcinoma (HCC)?. Diagnostics, 15.","DOI":"10.3390\/diagnostics15030252"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.2174\/0113892010298852240528123911","article-title":"Artificial Intelligence in Cancer Diagnosis: A Game-changer in Healthcare","volume":"26","author":"Sahoo","year":"2025","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1089\/aipo.2023.0011","article-title":"The Role of Artificial Intelligence in Early Cancer Detection: Exploring Early Clinical Applications","volume":"1","author":"Thaker","year":"2024","journal-title":"AI Precis. Oncol."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Martinino, A., Aloulou, M., Chatterjee, S., Scarano Pereira, J.P., Singhal, S., Patel, T., Kirchgesner, T.P., Agnes, S., Annunziata, S., and Treglia, G. (2022). Artificial Intelligence in the Diagnosis of Hepatocellular Carcinoma: A Systematic Review. J. Clin. Med., 11.","DOI":"10.3390\/jcm11216368"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"17981","DOI":"10.1038\/s41598-022-22514-4","article-title":"Artificial intelligence-based methods for fusion of electronic health records and imaging data","volume":"12","author":"Mohsen","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e406","DOI":"10.1016\/S2589-7500(22)00063-2","article-title":"AI recognition of patient race in medical imaging: A modelling study","volume":"4","author":"Gichoya","year":"2022","journal-title":"Lancet Digit. Health"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"159110","DOI":"10.1109\/ACCESS.2020.3020138","article-title":"A Natural Language Processing Pipeline of Chinese Free-text Radiology Reports for Liver Cancer Diagnosis","volume":"8","author":"Liu","year":"2020","journal-title":"IEEE Access"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.jhep.2022.01.014","article-title":"Artificial intelligence for the prevention and clinical management of hepatocellular carcinoma","volume":"76","author":"Calderaro","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.ccell.2021.04.002","article-title":"Artificial intelligence for clinical oncology","volume":"39","author":"Kann","year":"2021","journal-title":"Cancer Cell"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.hjdsi.2016.04.005","article-title":"Using active choice within the electronic health record to increase physician ordering and patient completion of high-value cancer screening tests","volume":"4","author":"Patel","year":"2016","journal-title":"Healthcare"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4103\/jfmpc.jfmpc_966_23","article-title":"A nudge strategy to increase the uptake of colorectal cancer screening in Saudi Arabia: A pragmatic randomized trial in the Hail region","volume":"13","author":"Elfakki","year":"2024","journal-title":"J. Fam. Med. Prim. Care"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1007\/s40615-021-01164-8","article-title":"Advancing Health Disparities Research: The Need to Include Asian American Subgroup Populations","volume":"9","author":"Yom","year":"2022","journal-title":"J. Racial Ethn. Health Disparities"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.jhep.2017.07.025","article-title":"Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression","volume":"67","author":"Waziry","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1053\/j.gastro.2018.04.008","article-title":"Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated with Direct-Acting Antiviral Agents","volume":"155","author":"Calvaruso","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2147\/JHC.S295330","article-title":"Decreased Incidence of Hepatocellular Carcinoma after Directly Acting Antiviral Therapy in Patients with Hepatitis C-Related Advanced Fibrosis and Cirrhosis","volume":"8","author":"Kilany","year":"2021","journal-title":"J. Hepatocell. Carcinoma"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/MEG.0000000000002741","article-title":"Prevalence, trends, and characteristics of metabolic dysfunction-associated steatotic liver disease among the US population aged 12\u201379 years","volume":"36","author":"Shen","year":"2024","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/apt.18346","article-title":"Prevalence of Low FIB-4 in MASLD-Related Hepatocellular Carcinoma: A Multicentre Study","volume":"61","author":"Tan","year":"2025","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/hep.28368","article-title":"Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study","volume":"63","author":"Piscaglia","year":"2016","journal-title":"Hepatology"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1016\/j.cgh.2022.11.019","article-title":"Mortality and Liver-Related Events in Lean Versus Non-Lean Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis","volume":"21","author":"Ha","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.3350\/cmh.2022.0424","article-title":"Non-alcoholic fatty liver disease: Definition and subtypes","volume":"29","author":"Han","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver, European Association for the Study of Diabetes, and European Association for the Study of Obesity (2024). EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary. Diabetologia, 67, 2375\u20132392.","DOI":"10.1007\/s00125-024-06196-3"},{"key":"ref_93","unstructured":"California Department of Public Health (2022). Asian and Pacific Islander Data Disaggregation Highlights, California Assembly Bill 1726, California Department of Public Health."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11113-020-09631-6","article-title":"The Critical Role of Racial\/Ethnic Data Disaggregation for Health Equity","volume":"40","author":"Kauh","year":"2021","journal-title":"Popul. Res. Policy Rev."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/MCG.0000000000002076","article-title":"Treatment and Survival Disparities in Asian Americans with Hepatocellular Carcinoma: The Need to Disaggregate a Diverse Cohort","volume":"59","author":"Hu","year":"2024","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/jnci\/djac055","article-title":"Charting a Path Towards Asian American Cancer Health Equity: A Way Forward","volume":"114","author":"Chen","year":"2022","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s13187-020-01741-1","article-title":"Use of Electronic Health Records at Federally Qualified Health Centers: A Potent Tool to Increase Viral Hepatitis Screening and Address the Climbing Incidence of Liver Cancer","volume":"36","author":"Pham","year":"2021","journal-title":"J. Cancer Educ."},{"key":"ref_98","first-page":"542","article-title":"Health insurance status and cancer stage at diagnosis and survival in the United States","volume":"72","author":"Zhao","year":"2022","journal-title":"CA Cancer J. Clin."}],"container-title":["Healthcare"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9032\/14\/10\/1314\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:09:41Z","timestamp":1779109781000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9032\/14\/10\/1314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":98,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["healthcare14101314"],"URL":"https:\/\/doi.org\/10.3390\/healthcare14101314","relation":{},"ISSN":["2227-9032"],"issn-type":[{"value":"2227-9032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]}}}